Smith+Nephew: A handheld options for robotic ortho surgeryCompetition continues to heat up in the robotic orthopedic surgery space, with Smith+Nephew (LON:SN) over the summer announcing the launch of its next-gen Cori surgical system.
Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. In addition to Cori, the British medtech giant also launched its Real Intelligence suite of digital surgery solutions that are meant to improve patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment and outcomes measurement.
The Cori surgical system represent next-generation robotics, according to Dr. Jimmy Chow, an orthopedic surgeon at the Orthopedic Institute of the West.
“Its efficient handheld form factor is ideal for surgery centers, which is where the market is moving, and it just erases away bone with the new bone milling technique,” Chow said in a recent Smith+Nephew news release. “The smart, intuitive software helps place and size the implant as well as balance gaps based on patient-specific anatomy and disease state.”
The new Cori system is small and portable, making it a good fit for ambulatory surgery centers (ASCs) and outpatient surgery. Its modular design means that S+N could scale Cori to handle other types of orthopedic surgeries.
“The introduction of the Cori surgical system’s handheld robotics, patient engagement tools and outcomes measurement are the very first steps in a long-term strategy to advance orthopedics using enabling technology,” said Skip Kiil, global president of orthopedics at Smith+Nephew.